Healthcare -
Biotechnology - NASDAQ - US
$ 0.3911
-0.19 %
$ 48.7 M
Market Cap
-0.62
P/E
MRSN - SHORT-TERM DEBT
Short-term Debt MRSN - Mersana Therapeutics, Inc.
16.4 M
LAST VALUE
132.03%
2 YEAR CAGR
41.47%
5 YEAR CAGR
0.00%
10 YEAR CAGR